Peer-reviewed publications

  1. Inocencio T, Sterling KL, Sayiner S, Minshall M, Kaye L, Hatipoğlu U. Budget impact analysis of a digital monitoring platform for COPD. Cost Effectiveness and Resource Allocation. 2023 21:36. (LINK).
  2. Woehrle H, Mastoridis P, Stempel D, Kaye L, Vuong V, Mezzi K. Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany. Pulmonary Therapy. 2023 Apr 30:1-6 (LINK).
  3. De Keyser H, Vuong V, Kaye L, Anderson III WC, Szefler S, Stempel DA. Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?. The Journal of Allergy and Clinical Immunology: In Practice. 2023 Apr 21. (LINK)
  4. Barrett M, Gondalia R, Vuong V, Kaye L, Hill AB, Attisha E, Holtrop T. Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use. Asthma Research and Practice. 2023 Dec;9(1):1-6. (LINK)
  5. Abernethy A, Adams L, Barrett M, Bechtel C, Brennan P, Butte A, Faulkner J, Fontaine E, Friedhoff S, Halamka J, Howell M. The Promise of Digital Health: The, Now, and the Future. NAM Perspectives. 2022. (Link)
  6. Parikh S, Henderson K, Gondalia R, Kaye L, Remmelink E, Thompson A, Barrett M. Perceptions of Environmental Influence and Environmental Information-Seeking Behavior Among People with Asthma and COPD. Frontiers in Digital Health. 2022; 4. (Link)
  7. Kaye L, Vuong V, Barrett MA, Boers E, Guilbert T. Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma. npj Primary Care Respiratory Medicine. 2022 Sep 2;32(1):1-4. (Link)
  8. Kaye L, Gondalia R, Thompson A, Stempel DA, Barrett MA. The relationship between objective app engagement and medication adherence in asthma and COPD: a retrospective analysis. Scientific reports. 2021 Dec 21;11(1):1-6. (Link)
  9. Su JG, Barrett MA, Combs V, Henderson K, Van Sickle D, Hogg C, Simrall G, Moyer SS, Tarini P, Wojcik O, Sublett J. Identifying impacts of air pollution on subacute asthma symptoms using digital medication sensors. International journal of epidemiology. 2021 Oct 19. (Link)
  10. Mosnaim GS, Stempel DA, Gonzalez C, Adams B, BenIsrael-Olive N, Gondalia R, Kaye L, Shalowitz M, Szefler S. Electronic medication monitoring versus self-reported use of inhaled corticosteroids and short-acting beta2-agonists in uncontrolled asthma. Journal of Asthma. 2021 Oct 22:1-4. (Link)
  11. Yawn BP, McCreary GM, Linnell JA, Pasquale CB, Malanga E, Choate R, Stempel DA, Gondalia R, Kaye L, Collison KA, Wu BS. Pilot Study of a Patient Experience with an ELLIPTA Inhaler Electronic Medication Monitor and Associated Integrated System: A Prospective Observational Study Using the COPD Patient-Powered Research Network. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 2021;8(4):488. (Link)
  12. Stempel DA, Kaye L, Bender BG. Defining Optimal Medication Adherence for Persistent Asthma and COPD. The Journal of Allergy and Clinical Immunology: In Practice. 2021 Dec 1;9(12):4239-42. (Link)
  13. Hynes L, Durkin K, Ewell T, Lilly C, Williford DN, Ahrabi-Nejad C, Noel D, Kothari V, Skoner D, Duncan CL. Pictorial versus written asthma action plans for youth: initial impact on regimen knowledge, medication adherence, symptom control, and family satisfaction. Journal of Asthma. 2021 Aug 16:1-4. (Link)
  14. Kaye L, Gondalia R, Barrett MA, Williams M, Stempel DA. Concurrent improvement observed in patient-reported burden and sensor-collected medication use among patients enrolled in a COPD digital health program. Frontiers in Digital Health. 2021;3:27. (Link)
  15. Jarrin R, Barrett MA, Kaye L, Sayiner S, von Leer A, Johns J, D’Andrea L, Nunez C, Ostrovsky A. Need for clarifying remote physiologic monitoring reimbursement during the COVID-19 pandemic: a respiratory disease case study. NPJ digital medicine. 2021 Mar 12;4(1):1-5. (Link)
  16. Moore A, Preece A, Sharma R, Heaney LG, Costello RW, Wise RA, Ludwig-Sengpiel A, Mosnaim G, Rees J, Tomlinson R, Tal-Singer R. A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients. European Respiratory Journal. 2021 Jan 1. (Link)
  17. Anderson III WC, Gondalia R, De Keyser HE, Kaye L, Szefler SJ, Stempel DA. Digital assessment of medication utilization by age and diagnosis of asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice. 2020 Nov 16. (Link)
  18. Mosnaim GS, Stempel DA, Gonzalez C, Adams B, BenIsrael-Olive N, Gondalia R, Kaye L, Shalowitz M, Szefler S. The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. 2020 Nov 16. (Link)
  19. Kan K, Fierstein J, Boon K, Kanaley M, Zavos P, Volerman A, Vojta D, Gupta RS. Parental quality of life and self-efficacy in pediatric asthma. Journal of Asthma. 2020 Feb 25:1-8. (Link)
  20. Kan K, Shaunfield S, Kanaley M, Chadha A, Boon K, Morales L, Davis MM, Vojta D, Gupta RS. Health provider perspectives of electronic medication monitoring in outpatient asthma care: a qualitative investigation using the consolidated framework for implementation research. Journal of Asthma. 2020 Nov 16:1-0. (Link)
  21. Mosnaim GS, Stempel H, Van Sickle D, Stempel DA. The Adoption and Implementation of Digital Health Care in the Post–COVID-19 Era. J Allergy Clin Immunol Pract. 2020; (Link)
  22. Bui AAT, Hosseini A, Rocchio R, Jacobs N, Ross MK, Okelo S, et al. Biomedical REAl-Time Health Evaluation (BREATHE): toward an mHealth informatics platform. JAMIA Open. 2020; (Link)
  23. Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020; (Link)
  24. Casey JA, Su JG, Henneman LRF, Zigler C, Neophytou AM, Catalano R, et al. Coal-fired power plant closures and retrofits reduce asthma morbidity in the local population. Nat Energy. 2020; (Link)
  25. Casey JA, Su JG, Henneman LRF, Zigler C, Neophytou AM, Catalano R, et al. Improved asthma outcomes observed in the vicinity of coal power plant retirement, retrofit and conversion to natural gas. Nat Energy. 2020; (Link)
  26. De Keyser HEH, Kaye L, Anderson WC, Gondalia R, Theye B, Szefler SJ, et al. Electronic medication monitors help determine adherence subgroups in asthma. Respir Med. 2020;164. (Link)
  27. Lin NY, Ramsey RR, Miller JL, McDowell KM, Zhang N, Hommel K, et al. Telehealth delivery of adherence and medication management system improves outcomes in inner-city children with asthma. Pediatr Pulmonol. 2020;1. (Link)
  28. Pepper JR, Barrett MA, Su JG, Merchant R, Henderson K, Van Sickle D, et al. Geospatial-temporal analysis of the impact of ozone on asthma rescue inhaler use. Environ Int. 2019;105331.
  29. Anderson WC, Gondalia R, Hoch HE, Kaye L, Barrett M, Szefler SJ, et al. Assessing asthma control: Comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the Asthma Control Test. J Asthma. 2019;1–8 (Link)
  30. Chen J, Kaye L, Tuffli M, Barrett MA, Jones-Ford S, Shenouda T, et al. Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis. JMIR Form Res. 2019;3:e13286. (Link)
  31. Gondalia R, Bender BG, Theye B, Stempel DA. Higher short-acting beta-agonist use is associated with greater COPD burden. Respir Med. 2019;158:110–3. (Link)
  32. Hynes L, Durkin K, Williford DN, Smith H, Skoner D, Lilly C, et al. Comparing Written Versus Pictorial Asthma Action Plans to Improve Asthma Management and Health Outcomes Among Children and Adolescents: Protocol of a Pilot and Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2019;8:e11733–e11733. (Link)
  33. Mehta P, Pan Z, Furuta GT, Kwan BM. Mobile health tool detects adherence rates in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2019; (Link)
  34. Alshabani K, Attaway AA, Smith MJ, Majumdar U, Rice R, Han X, et al. Electronic inhaler monitoring and healthcare utilization in chronic obstructive pulmonary disease. J Telemed Telecare. 2019; (Link)
  35. Mosnaim G, Stempel H, Szefler SJ, Stempel DA. Asthma Control — Time to Rethink Definitions and Criteria. J Allergy Clin Immunol Pract. 2019;7:1522–3. (Link)
  36. Anderson WC, Gondalia R, Hoch HE, Kaye L, Szefler SJ, Stempel DA. Screening for inhalation technique errors with electronic medication monitors. J Allergy Clin Immunol Pract. 2019; (Link)
  37. Williams AM, Phaneuf DJ, Barrett MA, Su JG. Short-term impact of PM2.5 on contemporaneous asthma medication use: Behavior and the value of pollution reductions. Proc Natl Acad Sci. 2019;116:5246 LP – 5253. (Link)
  38. Szefler SJ, Hoch HE, Tuffli M, Gondalia R, Barrett MA, Van Sickle D, et al. Quantifying beta-agonist utilization: Occasions or puffs? J Allergy Clin Immunol Pract. 2019;7:1088–90. (Link)
  39. Kenyon CC, Gruschow SM, Quarshie WO, Griffis H, Leach MC, Zorc JJ, et al. Controller adherence following hospital discharge in high risk children: A pilot randomized trial of text message reminders. J Asthma. 2019;56:95–103. (Link)
  40. Martin MA, Kapheim MG, Erwin K, Ignoffo S, McMahon K, O’Rourke A, et al. Childhood Asthma Disparities in Chicago: Developing Approaches to Health Inequities. Fam Community Health. 2018;41. (Link)
  41. Merchant R, Szefler SJ, Bender BG, Tuffli M, Barrett MA, Gondalia R, et al. Impact of a digital health intervention on asthma resource utilization. World Allergy Organ J. 2018;11:28. (Link)
  42. Merchant R, Inamdar R, Henderson K, Barrett M, Su GJ, Riley J, et al. Digital Health Intervention for Asthma: Patient-Reported Value and Usability. JMIR Mhealth Uhealth. (Link)
  43. Barrett M, Combs V, Su JG, Henderson K, Tuffli M. AIR Louisville: Addressing Asthma With Technology, Crowdsourcing, Cross-Sector Collaboration, And Policy. Health Aff. 2018;37:525–34. (Link)
  44. Van Sickle D, Barrett MA. Transforming Global Public Health Using Connected Medicines. Respir Drug Deliv. 2018;1:61–70. (Link)
  45. Hoch H, Kempe A, Brinton J, Szefler S. Feasibility of medication monitoring sensors in high risk asthmatic children. J Asthma. 2018;56:270–2. (Link)
  46. Magzamen S, Oron AP, Locke ER, Fan VS. Association of ambient pollution with inhaler use among patients with COPD: a panel study. Occup Environ Med. 2018;75:382 LP – 388. (Link)
  47. Barrett MA, Humblet O, Marcus JE, Henderson K, Smith T, Eid N, et al. Effect of a mobile health, sensor-driven asthma management platform on asthma control. Ann Allergy, Asthma Immunol. 2017;119:415-421.e1. (Link) (PDF)
  48. Sumino K, Locke ER, Magzamen S, Gylys-Colwell I, Humblet O, Nguyen HQ, et al. Use of a Remote Inhaler Monitoring Device to Measure Change in Inhaler Use with Chronic Obstructive Pulmonary Disease Exacerbations. J Aerosol Med Pulm Drug Deliv. 2017;jamp.2017.1383. (Link) (PDF)
  49. Adams SA, Leach MC, Feudtner C, Miller VA, Kenyon CC. Automated Adherence Reminders for High Risk Children With Asthma: A Research Protocol. JMIR Res Protoc. 2017;6:e48. (Link)
  50. Son J, Brennan PF, Zhou S. Correlated gamma-based hidden Markov model for the smart asthma management based on rescue inhaler usage. Stat Med. 2017;36:1619–37. (Link)
  51. Su JG, Barrett MA, Henderson K, Humblet O, Smith T, Sublett JW, et al. Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use. Environ Health Perspect. 2016/06/24. 2017;125:254–61. (Link) (PDF)
  52. Merchant RK, Inamdar R, Quade RC. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2016;4:455–63. (Link) (PDF)
  53. Fan VS, Gylys-Colwell I, Locke E, Sumino K, Nguyen HQ, Thomas RM, et al. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Respir Med. 2016;116:100–6. (Link) (PDF)
  54. Kim MS, Henderson KA, Van Sickle D. Using Connected Devices to Monitor Inhaler Use in the Real World. Respir Drug Deliv. 2016;1:37–44. (Link) (PDF)
  55. Van Sickle D, Maenner MJ, Barrett MA, Marcus JE. Monitoring and Improving Compliance and Asthma Control: Mapping Inhaler Use for Feedback to Patients, Physicians and Payers. Respir Drug Deliv. 2013;1:119–30. (Link) (PDF)
  56. Van Sickle D, Magzamen S, Truelove S, Morrison T. Remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma control. Baradaran HR, editor. PLoS One. 2013;8:e55335. (Link) (PDF)

Abstracts

  1. Elsey L, Wiffen L, Brown T, Chaudry A, Chauhan M, Stempel D, Kaye L, Hadwin J, Fowler S, Chauhan A. Adherence to controller therapy among patients with severe asthma enrolled in a 6-month digital intervention. InB34. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3121
  2. Cameron A, Barrett M, Malik A, Woodford C, Alpert N, Kaye L, Vuong V, Sterling KL. Predictors of adherence to asthma controller medication in pediatric, adolescent, and adult patients in the United States. InD102. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6644
  3. Cameron A, Barrett M, Malik A, Woodford C, Alpert N, Kaye L, Vuong V, Sterling KL. Predictors of exacerbations among pediatric, adolescent and adult patients with asthma in the United States. InD102. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6645
  4. Cameron A, Barrett M, Kaye L, Malik A, Woodford C, Sterling KL. Characteristics, healthcare resource use and costs among high-risk patients with COPD in the United States. InD102. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6643
  5. Akuthota P, Ivanova A, Song T, Stempel D, Szefler S. Medication adherence in patients with severe asthma enrolling in the NHLBI PrecISE study. InC31. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A4760
  6. Allen A, Vuong V, Boers E, Kaye L, Barrett M. Mobility and medication use trends surrounding high-rescue days in patients with chronic obstructive pulmonary disease. InD102. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6636
  7. Boers E, Allen A, Su J, Benjafield A, Malhotra A, Vuong V, Barrett M. Projecting global indoor and outdoor air pollution through 2050. InC17. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A4519
  8. Boers E, Allen A, Su J, Benjafield A, Malhotra A, Vuong V, Barrett M. Evaluation of machine learning models to project global indoor and outdoor air pollution through 2050. InC56. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A5391
  9. Kaye L, Vuong V, Benjafield A, Gupta P, Barrett M. Use of behavior change model to understand CPAP usage at one year. InD22. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6318
  10. Boers E, Allen A, Benjafield A, Barrett M, Malhotra A. The economic and health burden of COPD in North America: Forecasting through 2050. InB51. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3593
  11. Tellez D, Boers E, Kaye L, Vuong V, Barrett M. Sociodemographic predictors of digital health data sharing and concern with remote care in asthma and COPD patients. InB34. 2023 May. American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3150
  12. Cameron A, Barrett M, Malik A, Woodford C, Alpert N, Vuong V, Boers E, Kaye L, Sterling KL. Healthcare resource utilization and costs among patients with chronic obstructive pulmonary disease in the United States. EE612. 2022 December. Value in Health ISPOR. (LINK)
  13. Cameron A, Barrett M, Malik A, Woodford C, Alpert N, Kaye L, Vuong V, Sterling K. Predictors of medication adherence among patients with chronic obstructive pulmonary disease: a retrospective study. C196. 2023 April. Society of Behavioral Medicine.
  14. Kaye L, Vuong V, Gupta P, Benjafield A, Barrett M. Behavioral characteristics associated with PAP therapy usage in obstructive sleep apnea at one year. A229. 2023 April. Society of Behavioral Medicine.
  15. Kaye L, Sweet C, Myers V. Where evidence-based literature meets real world implementation: learnings from the industry frontlines. Symposium. 2023 April. Society of Behavioral Medicine.
  16. Lyson H, Kaye L, Barrett M, Olson B, Le J, Brazeal T. Feasibility of a clinical pharmacist-led digital health intervention with technical support outreach for self-management of asthma and COPD in ATA2023 Annual Conference & Expo March 4-6, 2023 San Antonio, Texas. Telemedicine and e-Health. Apr 2023. A-1-A-43. Vol 29, Issue 4, April 4, 2023. (LINK)
  17. Lyson, H., Vuong, V., Kaye, L., Boers, E., & Barrett, M. 2023. Short-acting beta-agonist (SABA) use by race and neighborhood socioeconomic status (nses) among participants enrolled in a Digital Health Program for asthma. Journal of Allergy and Clinical Immunology, 151(2). https://doi.org/10.1016/j.jaci.2022.12.143
  18. Vuong, V., Kaye, L., Barrett, M., & Allen, A. 2023. Identifying predictors of uncontrolled asthma symptoms despite high controller adherence. Journal of Allergy and Clinical Immunology, 151(2). https://doi.org/10.1016/j.jaci.2022.12.245
  19. Kaye, L., Vuong, V., Johns, J., Monacelli, S., & Barrett, M. 2023. Direct and indirect cost-savings associated with a digital intervention in uncontrolled asthma: A literature-based estimate. Journal of Allergy and Clinical Immunology, 151(2). https://doi.org/10.1016/j.jaci.2022.12.584
  20. Barrett, M., Cameron, A., Malik, A., Woodford, C., Alpert, N., Kaye, L., Vuong, V., & Sterling, K. 2023. Adherence to controller therapy among a large, diverse sample of asthma patients in the United States. Journal of Allergy and Clinical Immunology, 151(2). https://doi.org/10.1016/j.jaci.2022.12.319
  21. Cameron, A., Barrett, M., Malik, A., Woodford, C., Alpert, N., Kaye, L., Vuong, V., & Sterling, K. 2023. Healthcare Resource Use and costs among a large, diverse sample of asthma patients in the United States. Journal of Allergy and Clinical Immunology, 151(2). https://doi.org/10.1016/j.jaci.2022.12.577
  22. d’Ancona, G., Stewart-Kelcher, N., Patel, A., Holman, N., Green, L., Lam, J., Thompson, L., Nanzer, A., Jackson, D. J., Holmes, J., Propeller Health, A., Heaney, L. G., & Dhariwal, J. 2022. P203 assessing the concordance between patient-reported ICS adherence and objective E-monitoring of ICS therapy. ‘WALL-E’ – The Future of Digital Healthcare Delivery. https://doi.org/10.1136/thorax-2022-btsabstracts.337
  23. Holmes, J., Dennison, P., Jackson, D. J., D’Ancona, G., Mansur, A., Patel, P. H., Pfeffer, P., Chen, C., Shaw, D., Health, P., & Heaney, L. G. 2022. P147 use of a connected inhaler system in the pre-biologic assessment of patients with severe asthma. ‘The Force Awakens’ – The Asthma Patient Experience. https://doi.org/10.1136/thorax-2022-btsabstracts.282
  24. Barrett M, Vuong V, Boers E, Cameron A, Kaye L, Woodford C, Nunez CM, Sterling KL. Characterizing healthcare resource use among adults with COPD by presence of comorbidities. 2022. European Respiratory Society. 
  25. Barrett M, Vuong V, Boers, Cameron A, Kaye L, Woodford C, Nunez CM, Sterling KL. Healthcare resource utilization among adults with asthma by disease severity and presence of comorbidities. 2022. European Respiratory Society. 
  26. Woehrle H, Mastoridis P, Stempel DA, Kaye L, Vuong V, Mezzi K. Medication adherence and asthma control with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler® digital companion: interim analysis from Europe. 2022. European Respiratory Society. 
  27. Woehrle H, Mastoridis P, Stempel DA, Kaye L, Vuong V, Mezzi K. Medication adherence and asthma control with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler® digital companion: interim analysis from Japan and Germany. 2022. European Respiratory Society. 
  28. Boers E, Barrett M, Vuong V, Benjafield A, Su J, Kaye L, Tellez D, Nunez C, Malhotra A. An estimate of the global COPD prevalence in 2050: Disparities by income and gender. 2022. European Respiratory Society. 
  29. Barrett M, Vuong V, Boers E, Cameron A, Kaye L, Woodford C, Nunez CM, Sterling KL. Severity and Prevalence of Comorbidities Among Adults with Asthma in the United States. InA34. 2022 May. American Thoracic Society.
  30. Barrett M, Vuong V, Boers E, Cameron A, Kaye L, Woodford C, Nunez CM, Sterling KL. Disease Complexity and Prevalence of Comorbidities among Adults with COPD in the United States. InD21. 2022 May. American Thoracic Society.
  31. Boers E, Barrett M, Vuong V, Su J, Kaye L, Tellez D, Benjafield A, Nunez C, Malhotra A. Global Projections Regarding Smoking Prevalence Trends: A Model Based Analysis. American Journal of Respiratory and Critical Care Medicine. 2022;205:A1156. 
  32. Kaye L, Vuong V, Barrett M, Boers E, Guilbert TW. The Relationship between Self-reported Productivity and Digitally-captured Short-Acting Beta-Agonist (SABA) use in Asthma. American Journal of Respiratory and Critical Care Medicine. 2022;205:A4855. 
  33. Engel EB, Hill AC, Stempel D, Kaye L, Lyng G, Lockhart GC, Bowler RP. Wearable Sensors for Early Detection of COPD Exacerbations. American Journal of Respiratory and Critical Care Medicine. 2022;205:A1300. 
  34. Boers E, Kaye L, Vuong V, Barrett M. Concerns, mask-wearing and healthcare preferences among patients with asthma and COPD during the COVID-19 pandemic. A148. 2022 April. Society of Behavioral Medicine.
  35. Boers E, Vuong V, Kaye L, Su J, Tellez D, Benjafield A, Malhotra A, Barrett M. Global projections for smoking prevalence, 1990-2050: A comparison between developed and underdeveloped countries. C568. 2022 April. Society of Behavioral Medicine.
  36. Vuong V, Kaye L, Boers E, Barrett M. Improvement in productivity and short acting beta agonist use among patients with asthma using a digital health platform. C453. 2022 April. Society of Behavioral Medicine. 
  37. Vuong V, Kaye L, Barrett M, Stempel D. Feasibility of capturing self-reported asthma exacerbations with a digital self-management platform. Journal of Allergy and Clinical Immunology. 2022 Feb 1;149(2):AB184.
  38. Hoch H, Vuong V, Kaye L, Anderson W, Szefler S, Stempel D. Differences in medication adherence by dosing schedule among patients with asthma. Journal of Allergy and Clinical Immunology. 2022 Feb 1;149(2):AB232.
  39. Kaye L, Vuong V, Barrett M. Changes in remote care adoption for asthma during the COVID-19 pandemic. Journal of Allergy and Clinical Immunology. 2022 Feb 1;149(2):AB184.
  40. McCulloch M, Bothwell S, Brinton J, Anderson W. Impact of Electronic Medication Monitoring on Pediatric Asthma Severity and Control in a Real-World Multidisciplinary Clinic. Journal of Allergy and Clinical Immunology. 2022 Feb 1;149(2):AB232.
  41. Ramsey R, Guilbert T, Keidel K, Kroner J, Noser A, Biagini J, Curtsinger K, Durrani S, Stevens M, Martin L, Pilipenka V. Longitudinal Adherence to Inhaled Corticosteroids in Pediatric Patients with Difficult to Control Asthma. Journal of Allergy and Clinical Immunology. 2022 Feb 1;149(2):AB232.
  42. Benjafield A, Tellez D, Barrett M, Gondalia R, Nunez C, Wedzicha J, Malhotra A. An estimate of the European prevalence of COPD in 2050. 2021 European Respiratory Society. 
  43. Kaye L, Nagano J, Vuong V, Barrett M. Initial observed improvement in medication adherence maintained during the COVID-19 pandemic in asthma and COPD. 2021 European Respiratory Society. 
  44. Brazeal T, Kaye L, Gondalia R, Bassiouni M, Barrett M, Stempel D. Pre-post evaluation of healthcare resource utilization (HCRU) among patients with COPD enrolled in a digital health intervention.2021 European Respiratory Society. 
  45. Woehrle H, Mastoridis P, Stempel DA, Kaye L, Doan C, Mezzi K. Assessment of patient engagement and adherence with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler digital companion in asthma: interim analysis from Germany. 2021 European Respiratory Society. 
  46. Kaye L, Gondalia R, Stempel D, Barrett M. Care provider involvement in digital health programs associated with improved retention and asthma outcomes: a meta-analysis. In Annals of Behavioral Medicine. 2021 Apr 1 (Vol. 55, pp. S94-S94). 
  47. Kaye L, Gondalia R, Van Sickle D, Barrett M. Symptoms, access to healthcare, and telemedicine use among patients with asthma and COPD during the COVID-19 pandemic. Annals of Behavioral Medicine. 2021:S438-.
  48. Tellez D, Gondalia R, Barrett M, Benjafield A, Nunez CM, Malhotra A. An Estimate of the Americas’ Prevalence of Chronic Obstructive Pulmonary Disease in 2050. InTP41. 2021 May (pp. A2274-A2274). American Thoracic Society.
  49. Gondalia R, Kaye L, Barrett MA, Stempel DA. Controller Use Timing Among Participants Using Once-Daily Controller Medications in Asthma and COPD. In C8. 2021 May (pp. A1132-A1132). American Thoracic Society.
  50. Hirons N, Gondalia R, Kaye L, Stempel DA, Barrett MA. Predicting Daily Short-Acting Beta-Agonist (SABA) Inhaler Actuations Using a Time-Convolutional Neural Network. InTP15. 2021 May (pp. A1628-A1628). American Thoracic Society.
  51. Gondalia R, Lee BH, Barrett M, Benjafield A, Kaye L, Nunez CM, Malhotra A. Predicting Peak and Cumulative Ventilator Need for COVID-19 in the US: Development of an Epidemiological Model. InTP50. 2021 May (pp. A2610-A2610). American Thoracic Society.
  52. Kaye L, Gondalia R, Thompson A, Henderson K, Stempel DA, Barrett MA. Improvement in Inhaled Short-acting Beta-agonist (SABA) Use by Education and Income Among Adults Enrolled in a Digital Asthma Program. InTP15. TP015 UPDATES IN ADHERENCE AND TREATMENT OF LUNG DISEASE 2021 May (pp. A1608-A1608). American Thoracic Society.
  53. Barrett M, Gondalia R, Rowland C, Hill A, Attisha E, Kaye L, Holtrop T. Impact of a Digital Asthma Intervention on Short-acting Beta-agonist (SABA) Medication Use Among Medicaid-enrolled Children in Southwest Detroit. Journal of Allergy and Clinical Immunology. 2021 Feb 1;147(2):AB51.
  54. Theye B, Kaye L, Nagano J, Gondalia R, Barrett M, Stempel D. Increased adherence to controller medication maintained during the COVID-19 pandemic. The Journal of Allergy and Clinical Immunology. 2021 Feb;147(2):AB113.
  55. Kaye L, Gondalia R, Barrett M, Bender B, Stempel D. Weekly and Seasonal Variation in Controller Adherence by Age in Asthma. Journal of Allergy and Clinical Immunology. 2021 Feb 1;147(2):AB119.
  56. Gondalia R, Anderson W, Kaye L, De Keyser H, Barrett M, Szefler S, Stempel D. Medication adherence was greater in a digital asthma platform consisting of controller and rescue vs. controller inhalers alone. Journal of Allergy and Clinical Immunology. 2021 Feb 1;147(2):AB50.
  57. Gondalia R, Kaye L, Hirons N, Van Sickle D, Barret M. Association between online searches for influenza and reliever use among patients with COPD. 4093.0. 2020 October. American Public Health Association.
  58. Kaye L, Gondalia R, Van Sickle D, Stempel D, Barrett M. COPD Assessment Test (CAT) scores following a digital health intervention. European Respiratory Journal 2020; 56: Suppl. 64, 2444; https://erj.ersjournals.com/content/56/suppl_64/2444.short
  59. Gondalia R, Kaye L, Van Sickle D, Stempel D, Barrett M. Identifying subgroups of asthma patients for potential intervention using electronic medication monitors (EMM). European Respiratory Journal 2020; 56: Suppl. 64, 2668;  https://erj.ersjournals.com/content/56/suppl_64/2668.short
  60. McCreary G, Yawn B, Linnell J, Pasquale C, Malanga E, Choate R, et al. Assessment of Patient Interaction With a Dry Powder Inhaler Electronic Medication Monitor and Integrated System Within the Chronic Obstructive Pulmonary Disease Foundation Patient Powered Research Network. Chest. 2020;158:A1745–6. https://journal.chestnet.org/article/S0012-3692(20)33720-X/fulltext
  61. Hoch H, Gondalia R, Anderson WC, Kaye L, Szefler SJ, Stempel DA. Changes in Asthma Control Test Scores Following a Digital Health Intervention. Am J Respir Crit Care Med. 2020;A7747–A7747. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A7747
  62. Gondalia R, Anderson WC, Hoch HE, Kaye L, Szefler SJ, Stempel DA. Prevalence and Weekly Patterns of High Short-Acting Beta-Agonist Use in Asthma and COPD. Am J Respir Crit Care Med. 2020;A4775–A4775. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A4775
  63. Kaye L, Gondalia R, Remmelink E, Su J, Thompson A, Barrett M. Impact of Socioeconomic Status on the Relationship Between Smartphone App Engagement and Adherence Among Patients with Asthma. Am J Respir Crit Care Med. 2020;A4281–A4281. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A4281
  64. Mosnaim G, Gonzalez C, Adams B, Zhu L, QUAN P, BenIsrael Olive N, et al. A Randomized Controlled Trial of Electronic Medication Monitoring (EMM), Patient Mobile App and Health Care Provider Feedback compared to EMM alone on Inhaled Corticosteroids (ICS) and Short Acting Beta2 Agonists (SABA) Utilization and Asthma Control in A. J Allergy Clin Immunol. 2020;145:AB58. https://www.jacionline.org/article/S0091-6749(19)32409-1/fulltext
  65. Kaye L, Gondalia R, Gonzalez C, Adams B, Zhu L, QUAN P, et al. Electronic Medication Monitoring vs. Self-Reported Use of Inhaled Corticosteroids and Short Acting Beta2 Agonists in Adult Patients with Uncontrolled Asthma. J Allergy Clin Immunol. 2020;145:AB59. https://www.jacionline.org/article/S0091-6749(19)32411-X/fulltext
  66. Anderson W, Gondalia R, Hoch H, Szefler S, Stempel D. Prevalence and adherence trends of inhaled corticosteroid/long-acting bronchodilator (ICS/LABA) and ICS monotherapy by age group using electronic medication monitoring (EMM) data from 2017-2019. J Allergy Clin Immunol. 2020;145:AB209. https://www.jacionline.org/article/S0091-6749(19)31932-3/fulltext
  67. Parikh S, Henderson K, Gondalia R, Kaye L, Remmelink E, Thompson A, et al. Perceptions of environmental influence and preferences for receiving environmental information among patients with asthma and COPD. Ann Behav Med. 2020;
  68. Gondalia R, Remmelink E, Kaye L, Parikh S, Henderson K, Thompson A, et al. Patient characteristics associated with mobile application engagement for asthma and COPD self-management. Ann Behav Med. 2020;
  69. Kaye L, Gondalia R, Remmelink E, Henderson K, Parikh S, Thompson A, et al. The relationship between mobile app engagement and medication adherence in asthma and COPD. Ann Behav Med. 2020;
  70. 11.  Gondalia R, Anderson W, Hoch H, Szefler S, Stempel D. Prevalence of short-acting beta-agonist (SABA) along and in conjunction with inhaled corticosteroids (ICS). Ann Allergy, Asthma Immunol. 2019;123:S42. http://www.sciencedirect.com/science/article/pii/S108112061930883X
  71. Bender BG, Gondalia R, Stempel DA. Longitudinal trends in inhaled maintenance medication adherence in a digital health program varied by age and COPD Assessment Test score. Chest. 2019;156.
  72. Casey J. Symposium on Quasi-experimental designs. A multi-level analysis of the impact of changes in coal-fired power plant emissions on asthma-related healthcare utilization and symptoms in Louisville, Kentucky. Utrecht, Netherlands. Int Soc Environ Epidemiol. 2019; https://cbd.eventsair.com/QuickEventWebsitePortal/isee2019/program/Agenda/AgendaItemDetail?id=5cc80ed4-70dd-4bf8-b5bc-0564c4a2082e
  73. Moore A, Preece A, Sharma R, Heaney LG, Costello RW, Wise R, et al. A connected inhaler system improves adherence to fluticasone furoate/vilanterol in asthma. Eur Respir J. 2019;54:OA3561. http://erj.ersjournals.com/content/54/suppl_63/OA3561.abstract
  74. Hoch H, Gondalia R, Anderson W, Barrett M, Szefler S, Van Sickle D, et al. Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD. Eur Respir J. 2019;54:OA5350. http://erj.ersjournals.com/content/54/suppl_63/OA5350.abstract
  75. Anderson W, Gondalia R, Hoch H, Barrett M, Szefler S, Van Sickle D, et al. Nighttime short-acting beta-agonist (SABA) in asthma and COPD. Eur Respir J. 2019;54:PA859. http://erj.ersjournals.com/content/54/suppl_63/PA859.abstract
  76. Alshabani K, Smith M, Majumdar U, Attaway A, Rice R, Han X, et al. Prediction of COPD Exacerbations with Electronic Inhaler Monitoring. Am J Respir Crit Care Med. 2019;A5647–A5647. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A5647
  77. Hoch H, Meier M, Brinton J, Szefler SJ. Breathing Counts: Addressing Barriers to Medication Use in High Risk Children with Asthma. Am J Respir Crit Care Med. 2019;A7178–A7178. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A7178
  78. Hoch H, Pickett K, Brinton J, Szefler SJ. Evaluating Adherence Data in the Clinical Setting: What Tools Should We Use to Describe Behavior? Am J Respir Crit Care Med. 2019;A6735–A6735. https://www.atsjournals.org/action/showCitFormats?doi=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A6735
  79. Stanford RH, Averell CM, Johnson P, Buysman E, Carlyle M. Controller Adherence and Albuterol Use Among Adult Patients with Asthma on Once or Twice Daily Ics/laba Therapy Using Clip-on Sensor Technology to Assess Outcomes. Am J Respir Crit Care Med. 2019;A5929–A5929. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A5929
  80. Stanford RH, Averell CM, Johnson P, Buysman E, Carlyle M. Adherence and Asthma Control in Patients Using FF/VI with and Without a Clip-On Sensor That Monitors Adherence. Am J Respir Crit Care Med. 2019;A5930–A5930. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A5930
  81. Anderson WC, Hoch HE, Gondalia R, Kaye L, Szefler SJ, Stempel DA. Real-life Patterns of Short-Acting Beta-Agonist Use in Patients with COPD Vary by Time of Day and Season. Am J Respir Crit Care Med. 2019;A5933–A5933. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A5933
  82. Theye B, Gondalia R, Stempel DA. Monitoring Daily Maintenance Medication Adherence in Patients with COPD. Am J Respir Crit Care Med. 2019;A2986–A2986. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2986
  83. Gondalia R, Theye B, Stempel DA. The Association of Digitally Collected Short-Acting Beta-Agonist and Maintenance Medication Use and COPD Assessment Test. Am J Respir Crit Care Med. 2019;A5932–A5932. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A5932
  84. Hoch H, Anderson WC, Gondalia R, Kaye L, Szefler SJ, Stempel DA. Digitally Recorded Controller and Rescue Medication Use Vary by Age in Patients with Asthma. Am J Respir Crit Care Med. 2019;A5931–A5931. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A5931
  85. Gondalia R, Anderson W, Hoch H, Kaye L, Szefler SJ, Stempel DA. Assessing the sensitivity and specificity of self-reported short-acting beta agonist (SABA) inhaler use with electronic medication monitors (EMMs). J Allergy Clin Immunol. 2019;1431:AB169. https://www.jacionline.org/article/S0091-6749(18)32259-0/fulltext
  86. Anderson W, Hoch H, Gondalia R, Kaye L, Szefler SJ, Stempel DA. Digital assessment of asthma controller and rescue medication use as children transition into adulthood. J Allergy Clin Immunol. 2019;143:AB91. https://www.jacionline.org/article/S0091-6749(18)32022-0/abstract
  87. Zhu L, Ramirez Y, Villalobos-Terrazas D, Reyes K, BenIsrael-Olive N, Gondalia R, et al. Aligning Guideline Criteria for Asthma Control with Digitally Collected Data. J Allergy Clin Immunol. 2019;143:AB171. https://www.jacionline.org/article/S0091-6749(18)32265-6/abstract
  88. Parikh S, Kaye L, Gondalia R, Barrett M, Henderson K, Stempel D. Social Connectedness and Associated Digital Health Solutions in the COPD Patient Population: A Systematic Review. In: Annals of Behavioral Medicine. 2019. p. S538–S538. https://academic.oup.com/abm/article-abstract/53/Supplement_1/S1/5370264?redirectedFrom=fulltext
  89. Henderson K, Gondalia R, Kaye L, Remmelink E, Barrett M. COPD Patient Experience and Use of a Digital Health Platform. In: Annals of Behavioral Medicine. 2019. p. S303–S303. https://academic.oup.com/abm/article-abstract/53/Supplement_1/S1/5370264?redirectedFrom=fulltext
  90. Kaye L, Henderson K, Barrett M, Theye B, Gondalia R. Smartphone App Features Associated with Controller Inhaler Use Among Adults with Asthma. In: Annals of Behavioral Medicine. 2019. p. S259–S259. https://academic.oup.com/abm/article-abstract/53/Supplement_1/S1/5370264?redirectedFrom=fulltext
  91. Kaye L, Hoch H, Szefler SJ, Anderson W, Barrett M, Van Sickle D, et al. Real-Life Patterns of Asthma Controller Use Vary by Age, Time of Day and Season. J Allergy Clin Immunol. 2018;141:AB61. http://www.sciencedirect.com/science/article/pii/S009167491732095X
  92. Anderson W, Brinton J, Kaye L, Hoch H, Barrett M, Van Sickle D, et al. Real-Life Patterns of Short-Acting Beta-Agonist Use in Persistent Asthmatics Vary by Age, Time of Day, and Season. J Allergy Clin Immunol. 2018;141:AB61. http://www.sciencedirect.com/science/article/pii/S0091674917320973
  93. Ramirez E, Yeung D, Barrett M, Parson L, Simrall G. Public/Private Partnerships for Public Health: Lessons from the Santa Monica Wellbeing Project and AIR Louisville. Ann Behav Med. 2018;52:S427. https://academic.oup.com/abm/article-abstract/52/suppl_1/S1/4968064?redirectedFhttps://doi.org/10.1093/abm/kay013rom=fulltext
  94. Anderson W, Hoch H, Gondalia R, Kaye L, Theye B, Barrett M, et al. Frequency of improper inhaler technique identified by electronic medication monitor (EMM) actuation timing. Ann Allergy, Asthma Immunol. 2018;121:S7–8. https://www.annallergy.org/article/S1081-1206(18)30766-X/fulltext
  95. Hoch H, Kaye L, Gondalia R, Theye B, Barrett M, Van Sickle D, et al. Benefit of smartphone alerts to improve adherence to inhaled to inhaled asthma controllers. Ann Allergy, Asthma Immunol. 2018;121:S40. https://www.annallergy.org/article/S1081-1206(18)30873-1/abstract
  96. Carl JC, Isakov D, Winners S, Lucik T, Ferchau A, Antara A, et al. Use of Remote Electronic Monitoring Improves Asthma Outcomes Through Improved Adherence. Am J Respir Crit Care Med. 2018;A1164–A1164.
  97. Henderson K, Barrett M, Williams M. Evaluation of the impact of a digital health platform on asthma self-management e. Ann Behav Med. 2018;52:S729. https://academic.oup.com/abm/article-abstract/52/suppl_1/S1/4968064?redirectedFrom=fulltext
  98. Alshabani K, Smith M, Attawy A, Rice R, Wang X, Han X, et al. Reduction in COPD Related Healthcare Utilization with Use of Electronic Inhaler Monitoring. Am J Respir Crit Care Med. 2018;A4560–A4560. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A4560
  99. Alshabani K, Smith M, Attawy A, Rice R, Wang X, Han X, et al. Trends in Long-Acting Bronchodilator Adherence During Electronic Inhaler Monitoring. American Journal of Respiratory and Critical Care Medicine. 2018;A4558–A4558. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A4558
  100. Anderson WC, Hoch H, Kaye L, Tuffli M, Barrett M, Van Sickle D, et al. Association Between Objective Short-Acting Beta-Agonist Use and Self-Reported Asthma Control Test Scores Among Adults with Asthma. Am J Respir Crit Care Med. 2018;A4834–A4834. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A4834
  101. Hoch H, Anderson WC, Tuffli M, Kaye L, Barrett M, Van Sickle D, et al. Using Digital Technology to Identify Adherence Phenotypes May Identify Appropriate Time for Intervention. Am J Respir Crit Care Med. 2018;A4855–A4855. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A4855
  102. Anderson W, Hoch H, Gondalia R, Kaye L, Barrett M, Van Sickle D, et al. Asthma control evaluated with electronic medication monitor (EMM)-defined occasions of short-acting beta-agonist inhaler use. Ann Allergy, Asthma Immunol. 2018;121:S40. https://www.annallergy.org/article/S1081-1206(18)30872-X/fulltext
  103. Hoch H, Kaye L, Anderson W, Gondalia R, Barrett M, Tuffli M, et al. Comparing objective inhaler use among COPD and Asthma populations. Eur Respir J. 2018;52:PA2272. http://erj.ersjournals.com/content/52/suppl_62/PA2272.abstract
  104. 4Chen J, Jones-Ford S, Goeldi S, Barrett MA, Van Sickle D. Feasibility and Clinical Impact of Deploying a Digital Health Intervention on a Medicare Population with Asthma or Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med. 2017;A1722–A1722. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A1722
  105. Merchant R, Tuffli M, Barrett M, Hogg C, Van Sickle D, Stempel D. Impact of A Digital Health Intervention On Asthma Healthcare Utilization. Eur Respir J. 2017;50:PA4692. http://erj.ersjournals.com/content/50/suppl_61/PA4692.abstract
  106. Pepper J, Merchant R, Su J, Barrett M, Henderson K, Stempel D, et al. Evaluating asthma short-acting beta agonist use and outdoor air pollution: A geospatial-temporal analysis. Am Public Heal Assoc. 2017;
  107. Hoch H, Kempe A, Brinton J, Szefler S. Assessing the utility of asthma medication monitoring sensors in a group of high risk asthmatic children. Eur Respir J. 2017;50:PA598. http://erj.ersjournals.com/content/50/suppl_61/PA598.abstract
  108. Su J, Barrett M, Henderson K, Smith T, Combs V, Goeldi S, et al. Leveraging wireless inhaler sensors to estimate the impact of rising temperatures and pollutant levels on asthma symptoms. Am Public Heal Assoc. 2017; https://apha.confex.com/apha/2017/meetingapp.cgi/Paper/385963
  109. Hoch H, Meier MR, Brinton JT, Szefler SJ. A Feasibility Study of Daily Monitoring of Controller and Rescue Medication Use in a Pediatric Patient Population at High Risk of an Asthma Exacerbation. Am J Respir Crit Care Med. 2017;A2198–A2198. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A2198
  110. Merchant R, Inamdar R, Henderson K, Barrett MA, Van Sickle D. Digital Health Intervention for Asthma: Patient Perception of Usability and Value for Self-Management. Am J Respir Crit Care Med. 2017;A3326–A3326.
  111. Merchant R, Tuffli M, Barrett M, Hogg C, Van Sickle D. Interim Results of the Impact of a Digital Health Intervention on Asthma Healthcare Utilization. J Allergy Clin Immunol. 2017;139:AB250. http://www.sciencedirect.com/science/article/pii/S0091674916323235
  112. Chen J, Jones-Ford S, Goeldi S, Tuffli M, Barrett M, Van Sickle D, et al. Feasibility and clinical impact of deploying a digital health intervention in a Medicare population with COPD. Eur Respir J. 2017;50:PA390. http://erj.ersjournals.com/content/50/suppl_61/PA390.abstract
  113. Stempel D, Szefler S, Hoch H, Tuffli M, Barrett M, Van Sickle D. Daily pattern of ß2-agonists: understanding real-life use of rescue medication. Eur Respir J. 2017;50:PA3959. http://erj.ersjournals.com/content/50/suppl_61/PA3959.abstract
  114. Su J, Barrett M, Henderson K, Humblet O, Hogg C, Van Sickle D, et al. Identification of asthma short-acting bronchodilator use in space and time using mobile health tools. Am Assoc Geogr. 2016; http://app.core-apps.com/aagam2016/abstract/69ecab01e9a6a883b526db96dc5a3f5b
  115. Su J, Barrett M, Humblet O, Smith T, Hogg C, Henderson K, et al. Identifying Environmental Drivers of Asthma Hotspots using Real-Time Inhaler Sensors. Natl Assoc Chronic Dis Dir. 2016;
  116. Smith T, Van Sickle D, Barrett M, Henderson K, Humblet O, Hogg C, et al. Improving the Burden of Respiratory Disease Through Data-Driven Innovation: The AIR Louisville Program in Jefferson County, Kentucky. Am J Respir Crit Care Med. 2016;A1750–A1750. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A1750
  117. Van Sickle D, Barrett M, Humblet O, Su J, Henderson K, Smith T. Impact of a Mobile Health and Sensor-Driven Asthma Management Pilot Study on Symptoms, Control, and Self-Management. J Allergy Clin Immunol. 2016;137:AB9. http://www.sciencedirect.com/science/article/pii/S009167491501773X
  118. Su J, Barrett M, Henderson K, Humblet O, Smith T, Veronica C, et al. Application of wireless inhaler sensors to enhance asthma surveillance and inform municipal interventions. Am Public Heal Assoc. 2016; https://apha.confex.com/apha/144am/meetingapp.cgi/Paper/360095
  119. Van Sickle D, Barrett M, Humblet O, Henderson K, Hogg C. Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence. Eur Respir J. 2016;48:PA1018. http://erj.ersjournals.com/content/48/suppl_60/PA1018.abstract
  120. Merchant R, Inamdar R, Henderson K, Barrett M, Van Sickle D. Patient Reported Value and Usability of a Digital Health Intervention for Asthma. JMIR Iproceedings. 2016;2:e36. http://www.iproc.org/2016/1/e36/
  121. Van Sickle D, Su J, Barrett M, Humblet O, Henderson K, Smith T. Impact of a mobile health pilot study on asthma rescue inhaler use, control and self-management. Eur Respir J. 2015;46:PA2528. http://erj.ersjournals.com/content/46/suppl_59/PA2528.abstract
  122. Sumino K, Locke E, Magzamen S, Thomas R, Gylys-Colwell I, Nguyen HQ, et al. Use of a Remote Inhaler Monitor Device to Measure Change in Inhaler Use with COPD Exacerbations. Am J Respir Crit Care Med. 2015;A6181–A6181. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A6181
  123. Barrett M, Van Sickle D, Hogg C, Su J, Humblet O, Henderson K, et al. Identifying environmental drivers of asthma hotspots in Louisville, Kentucky, using sensors to capture spatially-explicit, real-time data on inhaler use: AIR Louisville program. Am Public Heal Assoc. 2015; https://apha.confex.com/apha/143am/webprogram/Paper334488.html
  124. Van Sickle D. Recent Advances in Digital Health Tools for Asthma and COPD Management in Underserved Populations. In: American Thoracic Society. Denver, CO; 2015.
  125. Smith T, Marcus J, Barrett M, Humblet O, Van Sickle D. Technology-driven asthma data program to inform regional policy: The municipal perspective. Am Public Heal Assoc. 2014; https://apha.confex.com/apha/142am/webprogram/Paper302567.html
  126. Van Sickle D, Barrett M, Marcus J, Humblet O, Smith T. Impact of a technology-driven asthma program on symptoms, control and self-management: The clinical perspective. Am Public Heal Assoc. 2014; https://apha.confex.com/apha/142am/webprogram/Paper303269.html
  127. Merchant R, Inamdar R, Quade R, Van Sickle D, Humblet O, Marcus J, et al. Interim Results From A Randomized, Controlled Trial Of Remote Monitoring Of Inhaled Bronchodilator Use On Asthma Control, Symptoms And Management. Am J Respir Crit Care Med. 2014;A1386–A1386. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A1386
  128. Barrett M, Humblet O, Marcus J, Smith T, Van Sickle D. Exploring drivers of asthma in Louisville with spatially-explicit, real-time data: The environmental perspective. Am Public Heal Assoc. 2014; https://apha.confex.com/apha/142am/webprogram/Paper303284.html
  129. Nesbitt L, Barrett M, Humblet O, Marcus J, Smith T, Van Sickle D. Technology-driven asthma data can support surveillance efforts: The public health perspective. Am Public Heal Assoc. 2014; https://apha.confex.com/apha/142am/webprogram/Paper303304.html
  130. Van Sickle D, Smith T, Barrett M. Louisville asthma data initiative – a municipal digital health program to improve self-management and public health surveillance of asthma. Am Public Heal Assoc. 2013; https://apha.confex.com/apha/141am/webprogram/Paper291945.html
  131. Merchant R, Inamdar R, Quade R, Van Sickle D, Maenner M, Patmas M. Interim Results From a Randomized, Controlled Trial of Remote Monitoring of Inhaled Bronchodilator Use on Asthma Control and Management. Chest. 2013;144:71A. https://journal.chestnet.org/article/S0012-3692(16)42704-2/fulltext
  132. Van Sickle D, Morrison TA. Weekly Feedback Summarizing Use Of Remotely Monitored Rescue Medication Improves Asthma Control. Am J Respir Crit Care Med. 2011;A4755–A4755. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4755
  133. Van Sickle D, Magzamen S, Truelove S. Online Feedback About Remotely Monitored Inhaled Bronchodilators Improves Composite Measures Of Asthma Control. Am J Respir Crit Care Med. 2010;A3127–A3127. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3127
  134. Van Sickle D. Development of a Networked Asthma Inhaler To Improve Clinical Management and Public Health Surveillance. Am J Respir Crit Care Med. 2009;A4065. https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A4065